These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7797578)

  • 1. Identification of key charged residues of human interleukin-5 in receptor binding and cellular activation.
    Graber P; Proudfoot AE; Talabot F; Bernard A; McKinnon M; Banks M; Fattah D; Solari R; Peitsch MC; Wells TN
    J Biol Chem; 1995 Jun; 270(26):15762-9. PubMed ID: 7797578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common beta-chain is necessary and sufficient for high affinity binding and signaling by all three ligands.
    Woodcock JM; Bagley CJ; Zacharakis B; Lopez AF
    J Biol Chem; 1996 Oct; 271(42):25999-6006. PubMed ID: 8824238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Cys motif in the common beta chain of the interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 receptors essential for disulfide-linked receptor heterodimerization and activation of all three receptors.
    Stomski FC; Woodcock JM; Zacharakis B; Bagley CJ; Sun Q; Lopez AF
    J Biol Chem; 1998 Jan; 273(2):1192-9. PubMed ID: 9422786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist.
    Tavernier J; Tuypens T; Verhee A; Plaetinck G; Devos R; Van der Heyden J; Guisez Y; Oefner C
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5194-8. PubMed ID: 7761472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisite mutagenesis of interleukin 5 differentiates sites for receptor recognition and receptor activation.
    Plugariu CG; Wu SJ; Zhang W; Chaiken I
    Biochemistry; 2000 Dec; 39(48):14939-49. PubMed ID: 11101310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic peptide interleukin 5 antagonists mimic CD turn recognition epitope for receptor alpha.
    Ruchala P; Varadi G; Ishino T; Scibek J; Bhattacharya M; Urbina C; Ryk DV; Uings I; Chaiken I
    Biopolymers; 2004 Apr; 73(5):556-68. PubMed ID: 15048779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble interleukin-5 receptor alpha-chain binding assays: use for screening and analysis of interleukin-5 mutants.
    Banks M; Graber P; Proudfoot AE; Arod CY; Allet B; Bernard AR; Sebille E; McKinnon M; Wells TN; Solari R
    Anal Biochem; 1995 Sep; 230(2):321-8. PubMed ID: 7503425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of residues in the first and fourth helices of human granulocyte-macrophage colony-stimulating factor involved in biologic activity and in binding to the alpha- and beta-chains of its receptor.
    Hercus TR; Cambareri B; Dottore M; Woodcock J; Bagley CJ; Vadas MA; Shannon MF; Lopez AF
    Blood; 1994 Jun; 83(12):3500-8. PubMed ID: 8204877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-5 and its receptor: which role do they play in the immune response?
    Koike M; Takatsu K
    Int Arch Allergy Immunol; 1994 May; 104(1):1-9. PubMed ID: 7950399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two contiguous residues in human interleukin-3, Asp21 and Glu22, selectively interact with the alpha- and beta-chains of its receptor and participate in function.
    Barry SC; Bagley CJ; Phillips J; Dottore M; Cambareri B; Moretti P; D'Andrea R; Goodall GJ; Shannon MF; Vadas MA
    J Biol Chem; 1994 Mar; 269(11):8488-92. PubMed ID: 7907592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils.
    Lopez AF; Vadas MA; Woodcock JM; Milton SE; Lewis A; Elliott MJ; Gillis D; Ireland R; Olwell E; Park LS
    J Biol Chem; 1991 Dec; 266(36):24741-7. PubMed ID: 1761568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for the interaction of the GM-CSF, IL-3 and IL-5 receptors with their ligands.
    Goodall GJ; Bagley CJ; Vadas MA; Lopez AF
    Growth Factors; 1993; 8(2):87-97. PubMed ID: 8466757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of potential antagonists of human interleukin 5 demonstrates their cross-reactivity with receptors for interleukin 3 and granulocyte-macrophage colony-stimulating factor.
    Wiekowski M; Prosser D; Taremi S; Tsarbopoulos A; Jenh CH; Chou CC; Lundell D; Zavodny P; Narula S
    Eur J Biochem; 1997 Jun; 246(3):625-32. PubMed ID: 9219518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial role of the residue R280 at the F'-G' loop of the human granulocyte/macrophage colony-stimulating factor receptor alpha chain for ligand recognition.
    Rajotte D; Cadieux C; Haman A; Wilkes BC; Clark SC; Hercus T; Woodcock JA; Lopez A; Hoang T
    J Exp Med; 1997 Jun; 185(11):1939-50. PubMed ID: 9166423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression.
    Gregory B; Kirchem A; Phipps S; Gevaert P; Pridgeon C; Rankin SM; Robinson DS
    J Immunol; 2003 Jun; 170(11):5359-66. PubMed ID: 12759409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The solution structure of the cytokine-binding domain of the common beta-chain of the receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5.
    Mulhern TD; Lopez AF; D'Andrea RJ; Gaunt C; Vandeleur L; Vadas MA; Booker GW; Bagley CJ
    J Mol Biol; 2000 Apr; 297(4):989-1001. PubMed ID: 10736232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of the common beta and specific alpha chains of the receptors for GM-CSF, IL-3, and IL-5 in endothelial cells.
    Colotta F; Bussolino F; Polentarutti N; Guglielmetti A; Sironi M; Bocchietto E; De Rossi M; Mantovani A
    Exp Cell Res; 1993 Jun; 206(2):311-7. PubMed ID: 7684696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed analysis of the IL-5-IL-5R alpha interaction: characterization of crucial residues on the ligand and the receptor.
    Cornelis S; Plaetinck G; Devos R; Van der Heyden J; Tavernier J; Sanderson CJ; Guisez Y; Fiers W
    EMBO J; 1995 Jul; 14(14):3395-402. PubMed ID: 7628440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors: insights from activated mutants of the common beta subunit.
    D'Andrea RJ; Gonda TJ
    Exp Hematol; 2000 Mar; 28(3):231-43. PubMed ID: 10720688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interleukin-5].
    Yamaguchi Y
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1287-93. PubMed ID: 8031174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.